Therapeutic area

Ophthalmology

Retinal diseases, macular degeneration, ocular inflammation, and anterior and posterior segment visual disorders.

Core & active disease programs

Age-Related Macular Degeneration

$486.2B+ attributable cost

$9.7B$+ drug spend

32 assets · 2 indications

Provisional & emerging programs (10)Early clinical pipeline & single-asset indications

Dry Eye Disease

Allergic Conjunctivitis

Leber Congenital Amaurosis

Non-Infectious Uveitis

Ocular Anesthesia

Ocular Inflammation

Optic Neuropathy

Retinitis Pigmentosa

Diabetic Macular Edema

Geographic Atrophy

All assets in Ophthalmology